Iranian Journal of Parasitology 2014. 9(1):120-124.

Anti-Toxoplasma gondii Antibody Levels in Blood Supply of Shiraz Blood Transfusion Institute, Iran.
Minoo Shaddel, Iraj Mirzaii-Dizgah, Mehran Hoshangi



Background: The prevalence of Toxoplasma gondii infection in the blood donors has been poorly studied. The aim of this study was to assess the prevalence of acute and chronic toxoplasmosis in blood products.

Methods: A total of 250 blood products (112 fresh frozen plasma and 138 packed cells) in the Blood Transfusion Institute, Shiraz, Iran were tested for spe-cific T. gondii antibodies (IgG and IgM) by ELISA method in 2013. Positive IgG anti-T. gondii samples were further tested for IgM anti-T. gondii antibody. A posi-tive IgG test with the negative and positive IgM test was interpreted as a chronic and acute toxoplasmosis respectively. The relationship of jobs, blood types, sex, marital status and residency of participants with chronic toxoplasmosis prevalence were statistically analyzed by χ2.

Results: Of 250 samples, 58 (23.2%) and one were positive for IgG anti-T. T. gondii (chronic) and IgM anti-T. T. gondii (acute) antibodies levels respectively. Twenty nine (25.9%) of fresh frozen plasma (FFP) samples were positive for IgG anti-T. gondiiiand 1(0.89%) of them was positive for IgM anti-T. gondiii antibody. Thirty (21.74%) of packed cell samples were positive for IgG anti-T. gondii anti-body. The prevalence of chronic toxoplasmosis was significantly higher in work-ers, farmers, house wives, unemployed and free jobs (P=0.007), people with low education levels (P=0.035) and B type of blood ABO system (P=0.0001). How-ever, there were no significant differences regarding to age, sex, marital status, residency and type of blood products.

Conclusions: There were chronic and acute toxoplasmosis in blood products and the prevalence of toxoplasmosis especially chronic form was high. Therefore screening of blood for T. gondii antibodies may be considered.


Blood products; IgG anti-T.gondii antibody; IgM anti-T.gondii antibody; Toxoplasma gondii

Full Text:



Wu YY, Snyder EL. Safety of the blood sup-ply: role of pathogen reduction. Blood Rev. 2003; 17(2):111-22.

Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol. 2012;7(1):1-17.

McCullough J. Progress toward a pathogen-free blood supply. Clin Infect Dis. 2003;37(1):88-95.

Alipour A, Shojaee S, Mohebali M, Teh-ranidoost M, Abdi Masoleh F, Keshavarz H. Toxoplasma infection in schizophrenia patients: a comparative study with control group. Iran J Parasitol. 2011; 6(2):31-7.

Siegel SE, Lunde MN, Gelderman AH, Halter-man RH, Brown JA, Levine AS, et al. Trans-mission of toxoplasmosis by leukocyte trans-fusion. Blood. 1971;37(4):388-94.

Sundar P, Mahadevan A, Jayshree RS, Sub-bakrishna DK, Shankar SK. Toxoplasma sero-prevalence in healthy voluntary blood donors from urban Karnataka. Indian J Med Res. 2007; 126(1):50-5.

Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, et al. Toxoplasmo-sis: prevalence and risk factors. J Obstet Gy-naecol. 2003;23(6):618-24.

Alvarado-Esquivel C, Mercado-Suarez MF, Rodrìguez-Briones A, Fallad-Torres L, Aya-la-Ayala JO, Nevarez-Piedra LJ, et al. Seroepi-demiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis. 2007; 7:75.

Chiang TY, Hsieh HH, Kuo MC, Chiu KT, Lin WC, Fan CK, et al. Seroepidemiology of Toxoplasma gondii Infection among Healthy Blood Donors in Taiwan. PLoS One. 2012;7(10):e48139.

Elhence P, Agarwal P, Prasad KN, Chaudhary RK. Seroprevalence of Toxoplasma gondii anti-bodies in North Indian blood donors: implica-tions for transfusion transmissible toxo-plasmosis. Transfus Apher Sci. 2010;43(1):37-40.

Liu Y, Zheng K, Chen M, Fu L, Du W, Shi Z. Study on detecting antibodies to Toxoplasma gondii in pooled serum of blood donors by Dot-IGSS. Southeast Asian J Trop Med Public Health. 2001;32(3):558-61.

Yazar S, Eser B, Yay M. Prevalence of anti-Toxoplasma gondii antibodies in Turkish blood donors. Ethiop Med J. 2006;44(3):257-61.

Yilmaz GR, Babür C, Kiliç S, Taylan Ozkan A, Beyaz E, Karakoç AE. Short communication: investigation of Toxoplasma gondii antibodies in blood donors by Sabin-Feldman Dye Test. Mikrobiyol Bul. 2006;40(4):375-81.

Sharif M, Daryani A, Barzegar G, Nasrolahei M. A seroepidemiological survey for toxoplas-mosis among schoolchildren of Sari, Northern Iran. Tropical Biomedicine. 2010; 27(2): 220–225 .

Salahi-Moghaddam A, Hafizi A. A serological study on Toxoplasma gondii infection among people in south of Tehran, Iran. Korean J Par-asitol. 2009;47(1):61-3.

Assmar M, Amirkhani A, Piazak N, Hovanesi-an A, Kooloobandi A, Etessami R. Tox-oplasmosis in Iran. Results of a seroepidemi-ological study. Bull Soc Pathol Exot. 1997; 90(1): 19-21.

Ghorbani M, Edrissian GH, Assad N. Serolog-ical survey of toxoplasmosis in the northern part of Iran, using indirect fluorescent antibody technique. Trans R Soc Trop Med Hyg. 1978;72(4):369-71.

Ghorbani M, Edrissian GH, Afshar A. Sero-logical survey of human toxoplasmosis in mountainous region of the north-west and southwest parts of Iran (1976-77). Trans R Soc Trop Med Hyg. 1981; 75: 38-40.

Nimir A, Othman A, Ee S, Musa Z, Majid IA, Kamarudin Z, et al. Latent toxoplasmosis in patients with different malignancy: a hospital based study. J Clin Med Res. 2010;2(3):117-20.

Longoni DV, Fumagalli R, Fumagalli M, Cap-pellini A, Uderzo C. Severe disseminated tox-oplasmosis after unrelated bone marrow trans-plantation: a case report. Haematologica. 2000;85(7):781-2.

Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, Norliza A, et al. Seroepidemiol-ogy of toxoplasmosis among HIV-infected pa-tients and healthy blood donors. Med J Malay-sia. 2002;57(3):304-10.

Tong DS, Yang J, Xu GX, Shen GQ. Serologi-cal investigation on Toxoplasma gondii infection in dialysis patients with renal insufficiency. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011;23(2):144-53.

Hashemi HJ, Saraei M. Seroprevalence of Toxo-plasma gondii in unmarried women in Qazvin, Islamic Republic of Iran. East Mediterr Health J. 2010;16(1):24-8.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.